Total: 10 results found.

Search for:
Search Only:

1. FAQs
(FAQs)
... a form of amino acid is administered through an IV before and after the PRRT is done. These amino acids are absorbed by the kidneys and protect them throughout the process. Does PRRT damage your bone ...
Created on 13 April 2011
2. Perspective on Generator-based PET radiopharmaceuticals
(Publications)
... a quantitative molecular imaging diagnosis of a disease (soft tissue tumours such as neuroendocrine cancer – imaged via peptidic molecular targeting vectors, or bone diseases such as metastases – imaged ...
Created on 11 April 2011
3. PRLT Results at Bad Berka
(PRLT)
... of PRLT. Patients received from 1 to 7 cycles. Bone mets were present in 81% of patients, 71% presented with lymph node mets and 16% presented with visceral mets. Patients who had at least one cycle ...
Created on 21 March 2011
4. Risks and Side Effects of PRLT
(PRLT)
Possible Risk Factors to Consider Before PRLT One of the first factors for risk to be considered is a patient’s bone marrow condition in the event there is severe bone marrow depression due to the following: ...
Created on 16 March 2011
5. About this site
(Uncategorised)
... Murfin: Diagnosed with carcinoid of the ileum in September 2008 w/ mets to lymph, liver and sacral bone. Primary and affected lymph nodes resected in October 2008. First PRRT w/ Lu-177 in September 2009. ...
Created on 20 January 2011
6. Nuclear Medicine Specialties
(Nuclear Medicine)
In addition to treating metastatic prostate cancer - Dr. Baum's team treat many of the following cancers with radionuclides: Thyroid cancer with I-131, Neuroblastoma with I-131 MIBG, Bone metastases with ...
Created on 19 July 2010
7. CCAN NET Cancer Patients Conference Long Island
(Past Conferences )
CCAN's annual conference was held in Long Island, New York on August 20th 2011.  The theme of the day long conference was "Multidisciplinary Approach to the Diagnosis Treatment and Monitoring of NETs." ...
Created on 20 August 2011
8. Road to Basel - Terry Y.
(Basel)
... the test results for qualification to Basel included: • current CT scan (within the past 60 days) • current octreoscan • liver ultrasound • bone marrow biopsy (see note) • blood ...
Created on 12 June 2011
9. Jim M.
(Bad Berka)
... CT results confirmed that the first treatment had reduced my overall tumor load by 50%!! Improvement was seen in all areas including liver mets, bone mets, and lymph nodes. A roaring success. Professor ...
Created on 22 April 2011
10. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
(In the News)
... trivalent therapeutic radiomentals) • Ga-68 imagining in clinical practice – worldwide experience (Europe, Asia, South America, Africa) • Ga-68 for imaging bone metastases • Current progress and ...
Created on 07 April 2011